MedPath

Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma

Not Applicable
Not yet recruiting
Conditions
Nasopharyngeal Carcinoma
Registration Number
NCT06572293
Lead Sponsor
Fujian Cancer Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Able to provide informed consent;<br><br> 2. Have completed radiotherapy treatment for loco-regional nasopharyngeal carcinoma<br> without clinical sign of distance metastatis;<br><br> 3. Aged 18 years and above;<br><br> 4. Expected survival =6 months;<br><br> 5. Read, understand Chinese characters and speak Mandarin.<br><br>Exclusion Criteria:<br><br> 1. Previous history of other malignancies, mental illness or cognitive impairment (MMSE<br> score < 27 points);<br><br> 2. Unstable medical or psychiatric conditions<br><br> 3. Inability to communicate effectively in mandarin<br><br> 4. Pregnant women or lactating women.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life score (EORTC QLQ C30);Quality of life score QLQ-HN35
Secondary Outcome Measures
NameTimeMethod
Changes in knowledge, skill, and confidence for self-management;Changes in anxiety;Changes in self-management;Changes in fear of recurrence;Changes in Depression;Changes in work ability
© Copyright 2025. All Rights Reserved by MedPath